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Summary We describe the creation, and the first 2 years experience, of the Gambian National Cancer
Registry. The major problems involved in the creation of such a registry in a developing country are discussed.
The data accumulated show a low overall rate of cancer incidence compared to more developed parts of the
world and indicate that the prevalent cancers, hepatoma, carcinoma of the cervix and lymphoma, are likely to
be due to infectious agents. It is hoped that immunisation of children under one year against hepatitis B will
drastically reduce the incidence of hepatocellular carcinoma.
The Gambia National Cancer Registry has been created as
part of the Gambia Hepatitis Intervention Study (GHIS).
This study is designed to introduce hepatitis B vaccine into
the national Expanded Programme of Immunization (EPI) in
a phased manner to allow the evaluation of the protective
effectiveness of the vaccine against chronic liver disease,
specifically primary hepatocellular carcinoma. The design of
this study (The Gambia Hepatitis Study Group, 1987) and of
the integration of the vaccine into the EPI (The Gambia
Hepatitis Study Group, 1989) are described in detail else-
where. The outcome of this study is to be measured through
cancer registration over the next 35 years. The Registry has
been established from the beginning of the immunisation
programme to allow validation of the assumptions made in
the sample size estimates for the study. All cancers are
registered although there is special emphasis on liver tu-
mours.
Methods
The Gambia has three major tertiary care facilities; the Royal
Victoria Hospital in Banjul, the inpatient ward at the Medi-
cal Research Council (MRC) laboratories in Fajara and, in
the eastern part of the country, Bansang Hospital. In addi-
tion, there are doctors at five of the major health centres, at
MRC field stations and at mission clinics (see Figure 1).
These doctors all contribute to the Registry as do all the
private physicians in the country. The cancer registrar visits
all these centres regularly to encourage the staff to register
cases, to collect completed forms and to search the clinic
records for further information. The principal investigator of
the GHIS holds a weekly clinic in Fajara to which any
patients may be referred for investigation and management.
Physicians are particularly encouraged to refer all patients
who might possibly have liver disease.
A portable ultrasound machine is used at this clinic and at
weekly sessions at the Royal Victoria Hospital to facilitate
diagnosis. Alpha-fetoprotein estimation is available at the
MRC Laboratories using immunodiffusion for rapid diag-
nosis, and this is later re-estimated for all sera using a
radioimmunoassay. Neither ultrasound nor alpha-fetoprotein
estimation is available outside these two centres and thus
such methods of diagnosis are only available to people refer-
red to the western end of the country. There is no his-
topathologist in The Gambia. However, the pathologist in
charge of the routine laboratories in Banjul and the senior
physician at MRC routinely send specimens to the UK for
diagnosis. Post-mortems are rarely performed for cultural
and religious reasons. Registration of death only takes place
within the city of Banjul as a death certificate is required for
burials within the city. Thus only 6% of The Gambia's
population is covered by a death registration system. Cause
of death certified by a physician is required for the death
certificate. This death register is inspected regularly for
deaths attributed to neoplasia which have been missed by the
reporting system.
A specific problem of registries in developing countries is
the estimation of age and the determination of nationality.
These difficulties arise because few Gambians know their age
accurately and there is considerable inter-country migration
in West Africa. Specifically, the sick cross national borders in
pursuit of better health care. For these reasons the cancer
registrar attempts to interview as many as possible of the
patients with cancer personally. This allows the use of an
algorithm based on family structure to estimate age. The
recent widespread introduction of identity cards for adults
has reduced the necessity for this to some degree as the card
includes the year of birth of the individual. A patient is
considered eligible for the register if they have resided in The
Gambia for 3 years before first presentation with symptoms.
This effectively excludes persons who come to The Gambia
purely for medical care and is also the residency status used
by the census to determine nationality.
All health centre staff have attended training courses in
association with the introduction of the hepatitis B vaccine.
These courses have also emphasised the diagnostic charac-
teristics of cancer and encouraged health workers to refer
patients with such characteristics to a doctor for a more
accurate diagnosis.
All diagnoses are coded to ICD-0 by the cancer registrar
with assistance from the GHIS principal investigator as
necessary. The cancer registrar was trained initially at the
East Anglia Cancer Registry in Cambridge, UK.
The population denominators used have been derived from
the 1983 national census with adjustment for population
growth. The estimated population figures for January 1988
by age and sex are presented in Table I. Standardisation of
rates was performed by the direct method using the standard
'world' population-widely used for cancer incidence stan-
dardisation (Waterhouse et al., 1982).
Results
In the first 2 years of operation 559 patients suffering from
cancer have been registered. The numbers of patients and
crude rates per 100,000 per annum by sex and site are shown
in Table II. In both men and women the commonest tumour
is hepatocellular carcinoma. In women, cervical cancer is
almost equally as frequent as liver cancer and breast cancer is
the third most common tumour. In men the second com-
monest cancer is that of the stomach but this has a low
incidence. Lymph node neoplasms are in third rank in men
and fourth in women. Two of these tumours were Kaposi's
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Figure 1 Observed and expected numbers of liver cancer by health region, both sexes combined. Registry reporting units: A,
tertiary care facilities; 0, medical officer at health centre; *, private hospitals.
sarcoma with no skin lesion, six were Burkitt's tumour, but
only in one was this diagnosis based on histology. There were
two patients with Hodgkin's disease. Twelve of the remainder
had histology which showed various forms of non-Hodgkin's
lymphoma, two of which were T cell lymphomas. No cases
of cutaneous Kaposi's sarcoma have been seen despite clini-
cal awareness and surveillance.
The distribution of all cancers by 10-year age bands and
sex is shown in Table III with the corresponding rates. The
incidence rises with age in both sexes until the age of 65
years. The rates over this age are lower. Rates are
consistently higher in males than females except in the
15-24-year age stratum.
Table I Population estimates (in thousands) forJanuary 1988 for The
Gambia by age and sex
Age (years) Males Females Total
0- 14 173 170 343
15-24 64 74 138
25-34 56 65 121
35-44 36 35 71
45-54 25 20 45
55-64 15 12 27
65 16 13 29
Total 385 389 774
Table II Cancer numbers and crude rates per 100,000 per annum in The Gambia by site
and sex from July 1986 to June 1988
Site (ICD-0 code)
Lip (140)
Tongue (141)
Salivary glands (142)
Floor of mouth (144)
Other parts of mouth (145)
Nasopharynx (147)
Oesophagus (150)
Stomach (151)
Small intestine (152)
Colon (153)
Rectum (154)
Liver (155)
Pancreas (157)
Peritoneum (158)
Other digestive (159)
Nasal cavities, etc. (160)
Larynx (161)
Lung (162)
Haematopoietic (169)
Bone (170)
Soft tissue (171)
Skin (173)
Breast (174)
Uterus NOS (179)
Cervix (180)
Body of uterus (182)
Other and unspecified
female genital organs (184)
Ovary (183)
Prostate (185)
Testis (186)
Penis and other male
genital organs (187)
Bladder (188)
Kidney (189)
Eye (190)
Brain (191)
Thyroid (193)
III defined sites (195)
Lymph nodes (196)
Unknown sites (199)
All sites (140-199)
Male
No. Rate
1 0.1
1 0.1
2 0.3
2 0.3
2 0.3
7 0.9
24 3.1
2 0.3
2 0.3
5 0.7
175 22.8
5 0.7
3 0.4
1 0.1
5 0.7
9 1.2
7 0.9
5 0.7
2 0.3
15 1.9
9
4
3
7
2
2
4
18
5
332
1.2
0.5
0.4
0.9
0.3
0.3
0.1
0.1
0.5
2.3
0.7
43.1
Female
No. Rate
1 0.1
2 0.3
1 0.1
2
9
1
4
53
2
1
l
2
3
5
5
21
9
50
11
2
13
5
3
4
4
11
3
227
0.3
1.2
0.1
0.5
6.8
0.3
0.1
0.1
0.3
0.4
0.7
0.7
2.7
1.2
6.4
1.4
0.3
1.7
0.7
0.4
0.5
0.1
0.4
1.4
0.4
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Table III Numbers and age-specific rates per 100,000 per annum for
all cancers by sex from July 1986 to June 1988
Male Female
Age (years) No.a Rate No.a Rate
0-14 9 2.61 8 2.36
15-24 12 9.18 19 13.01
25-34 47 42.66 38 29.62
35-44 63 86.09 56 80.57
45-54 66 133.73 45 108.92
55-64 72 234.73 35 147.16
> 65 63 199.40 26 96.74
All ages 332 43.13 227 29.19
'47 male and 41 female cases with ages unknown were distributed
according to the ages of the other cases.
The only sites for which the number of diagnoses is
sufficient to analyse by age are primary hepatocellular car-
cinoma and cervix uteri. The distribution ofthese tumours by
age and sex is shown in Table IV, the rates again rising
consistently with age. The rates of hepatocellular carcinoma
in men are three times those in women.
The basis of the diagnosis for all registered tumours, and
for hepatocellular carcinoma alone, is shown in Table V. The
immunological test referred to is alpha-fetoprotein estimation
and the clinical diagnoses included the use of ultrasound
which was employed in 96% of the clinical diagnoses of liver
cancer. Alpha-fetoprotein estimation has been shown to have
a sensitivity and specificity of greater than 90% in the diag-
nosis of hepatocellular carcinoma when a cut-off of
400ngmlh' is used (Kew, 1975). This is improved in the
Sahelian region by the addition of ultrasound examination
(Tortey et al., 1985). The death registers in Banjul were the
initial source of information for 2% of the cancers registered
but in all but 14 cases further information was available from
other records to confirm the diagnosis.
An age-standardised incidence ratio for liver cancer was
calculated for each of the three health regions in the country.
These are shown in Figure 1. The ratio in the eastern part
of the country, which is the furthest from the major health
facilities, is lower than in the other two. The vast majority
(96%) of liver cancers were diagnosed at either the Royal
Victoria Hospital or the MRC Laboratories, both of which
are at the western end of the country. If the residents in the
Western Health Region of the country are considered alone,
the crude liver cancer rates in Table IV increase to 31.9 and
8.6 per 100,000 per annum for males and females respec-
tively.
Discussion
The Gambian National Cancer Registry currently represents
the only functioning national, population based registry on
the continent of Africa. The overall rates of cancer recorded
are similar to those recorded in the Dakar, Senegal registry
for 1969-1974 (Waterhouse et al., 1982) but lower than
those in the Bamako, Mali registry for 1987-1988 (Bayo et
al., 1990). This may result from a number of factors. The
Dakar and Bamako registries are both urban, they have
better diagnostic facilities than those in The Gambia, and in
Bamako the definition of residence in the city was taken as a
duration of 3 months. This last consideration may in partic-
ular bias the Mali figures upwards as a number of patients
may have moved to Bamako specifically to seek health care.
The rates of liver cancer also vary between the three
registries, as can be seen in Table VI, with the rates for males
in the Bamako registry being considerably higher than else-
where. The Bamako registry also has higher rates of cancer
at a number of sites, notably cervix cancer, stomach cancer
in both sexes and breast cancer. In contrast, the Dakar
register shows similar rates at all these sites except cervical
cancer. It seems most probable that this site is underascer-
tained in The Gambia rather than this being a true difference
in incidence.
The steady rise of all cancer rates with age in both sexes
suggests that the method of age determination is not too
inaccurate. The decline in rates at old ages probably repre-
sents underascertainment again as the elderly are less likely
to make long journeys to seek health care and have less belief
in 'Western' medicine than the younger generations.
The rates of liver cancer by age (Table IV) show a similar
effect but are remarkable for the young age of many of the
Table IV Numbers and age-specific rates per 100,000 for primary liver and cervix uteri
cancer in The Gambia by sex from July 1986 to June 1988
Male (liver) Female (liver) Female (cervix)
Age (years) No.a Rate No.' Rate No. Rate
0-14 0 0 1 0.30 0 0
15-24 3 2.68 1 0.86 2 1.15
25-34 37 33.22 5 3.91 13 9.86
35-44 41 53.93 14 19.96 12 16.62
45-54 35 69.75 14 33.92 10 25.45
55-64 28 89.90 13 53.9 9 39.59
> 65 31 98.90 5 19.16 4 13.19
All ages 175 22.7 53 6.82 50 6.43
a23maleand 11 femalecaseswithageunknownweredistributedaccordingtotheagesof
the other cases.
Table V Distribution ofcancer cases from July 1986 to June 1988 by basis of
diagnosis
All sites Liver
Basis ofdiagnosis No. Proportion No. Proportion
Clinical 283 50.6% 109a 47.8%
Exploratory surgery/
autopsy 38 6.8% 1 0.4%
Biochemistry/
immunological test 105b 18.8% 105b 46.1%
Cytology/haematology 7 1.3% 1 0.4%
Histology of metastasis 4 0.7% - -
Histology ofprimary 106 19.0% 6 2.6%
Unknown 16 2.9% 6 2.6%
Total 559 100.0% 228 100.0%
'Includes ultrasound. bEstimates ofalpha-fetoprotein.650 E. BAH et al.
Table VI Cancer incidence, all sites, primary liver and cervix uteri cancer, age-adjusteda
rates per 100,000
All sites Liver Cervix uterib
Male Female Male Female
The Gambia
(1986-1988) 66 47 34 13 11
Mali
(1987) 120 88 49 15 21
Senegal
(1969-1974) 76 76 26 9 17
Northern Europe
(1970) >250 >200 <2 < 1 5-20
aRates adjusted to 'world' standard population. bCervix + uterus NOS.
patients. Some bias in age estimation may have affected the
age groups 15-24 and 25-34 as young people, men in
particular, tend to exaggerate their age. This age distribution
of liver cancer is also seen in the Dakar and Bamako regis-
tries. The other population based registry in West Africa,
that in Ibadan, Nigeria (Waterhouse et al., 1976), has not
been compared to these figures as it shows surprisingly low
overall rates of cancer and of liver cancer in particular. This
registry is not in the Sahelian region and it is quite clear that
the pattern of cancer in the Sahel is different from the areas
further south, particularly with regard to liver cancer (Parkin
et al., 1984). Thus liver cancer constituted 16% of all cancers
in males in Liberia (Sobo, 1982) compared to 53% in The
Gambia.
The absence of an in-country histopathology service dis-
courages clinicians from taking biopsies, particularly when
the neoplasm is advanced and no treatment is available. The
UK pathologists provide a valuable and rapid service, how-
ever, and allow the prompt treatment of those neoplasms for
which treatment is available, such as lymphoma. The fact
that only 20% of neoplasms are histologically confirmed
(Table V) is mitigated to some extent by the availability of
alpha-fetoprotein assay and ultrasound examination.
The low observed number of cases of liver cancer com-
pared to the expectation in the Eastern region probably
represents underascertainment rather than a true difference in
disease incidence. Thus the figures for the Western region are
probably more representative of the distribution of this
cancer in The Gambia. The four areas of poor ascertainment
- cervix cancer, old age, rural areas and histology - are the
focus of efforts to improve the Registry over the next years.
However, the Registry has already established that it is possi-
ble to have reasonable country-wide registration. It is hoped
that the Registry may be integrated with the national AIDS
programme to allow examination oftime trends in neoplasms
related to human immunodeficiency virus.
The data are remarkable for the low overall rate of cancer
compared to more developed parts of the world (see Table
VI) and that the major cancers - hepatoma, cervix and
lymphoid - are likely to be due to infectious agents.
Case-control studies have suggested that 80% of hepatocel-
lular carcinoma in the Senegambian region is attributable to
persistent hepatitis B infection. This opens the possibility of
prevention and the Gambia Hepatitis Intervention Study, by
immunising children under 1 year against hepatitis B, hopes
to prevent the most frequent cancer in the country (The
Gambia Hepatitis Study Group, 1987, 1989).
We wish to thank all the health personnel in The Gambia who have
contributed to the Registry and the Medical Research Council for
assistance with the logistics of the Registry. We are grateful to the
UK pathologists at Northwick Park and University College Hos-
pitals who provide a prompt and excellent histological service.
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